|
|
| Sequent Scientific Limited |
|
Financials-Sequent Scientific Limited| Sector: Pharmaceuticals - Others | | BSE:512529 | NSE:SEQUENT | Bloomberg:SEQ@IN | Reuters:SEQU.BO | | Market Lot: 1 | Face Value: 2 | ISIN Demat: INE807F01027 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2020(3) |
31-Dec-2019(3) |
% Change |
| Sales of Products/Services |
705.72 |
617.99 |
14.20 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
56.69 |
21.14 |
168.16 |
| Total Income |
762.41 |
639.13 |
19.29 |
| Total Expenses |
-601.30 |
-592.21 |
1.53 |
| OPBDIT |
1363.71 |
1231.34 |
10.75 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-21.93 |
-592.21 |
-96.30 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-39.42 |
-17.74 |
122.21 |
| After Tax Profit |
121.69 |
29.18 |
317.03 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-06(12) |
|
31-Mar-05(12) |
|
31-Mar-04(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
323.48 |
93.91 |
254.69 |
99.47 |
198.81 |
99.46 |
| Operating Income (OI) |
344.44 |
100.00 |
256.06 |
100.00 |
199.88 |
100.00 |
| OPBDIT |
57.54 |
16.71 |
48.78 |
19.05 |
43.38 |
21.70 |
| OPBDT |
57.19 |
16.60 |
48.28 |
18.86 |
43.10 |
21.56 |
| OPBT |
51.84 |
15.05 |
43.55 |
17.01 |
38.82 |
19.42 |
| Non-Operating Income |
2.33 |
0.68 |
3.90 |
1.52 |
2.08 |
1.04 |
| Extraordinary/Prior Period |
-1.47 |
-0.43 |
-2.74 |
-1.07 |
-3.35 |
-1.68 |
| Tax |
15.17 |
4.41 |
14.00 |
5.47 |
8.00 |
4.00 |
| Profit after tax(PAT) |
37.52 |
10.89 |
30.70 |
11.99 |
29.55 |
14.78 |
| Cash Profit |
42.87 |
12.45 |
35.44 |
13.84 |
33.82 |
16.92 |
| Dividend-Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| As on |
31-Mar-06 |
|
31-Mar-05 |
|
31-Mar-04 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
131.70 |
47.96 |
119.39 |
44.01 |
103.06 |
43.31 |
| Net Block |
112.72 |
41.05 |
105.76 |
38.99 |
93.84 |
39.44 |
| Capital WIP |
6.18 |
2.25 |
2.42 |
0.89 |
1.07 |
0.45 |
| Investments |
0.92 |
0.34 |
0.00 |
0.00 |
0.00 |
0.00 |
| Inventory |
18.78 |
6.84 |
17.04 |
6.28 |
16.85 |
7.08 |
| Receivables |
80.96 |
29.48 |
55.64 |
20.51 |
45.34 |
19.05 |
| Other Current Assets |
55.04 |
20.04 |
90.41 |
33.33 |
80.85 |
33.98 |
| Balance Sheet Total(BT) |
274.60 |
100.00 |
271.26 |
100.00 |
237.93 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
65.00 |
23.67 |
65.00 |
23.96 |
65.00 |
27.32 |
| Reserves |
133.08 |
48.46 |
95.56 |
35.23 |
64.85 |
27.26 |
| Total Debt |
0.00 |
0.00 |
54.55 |
20.11 |
61.55 |
25.87 |
| Creditors and Acceptances |
49.51 |
18.03 |
22.41 |
8.26 |
29.69 |
12.48 |
| Other current liab/prov. |
27.01 |
9.84 |
33.75 |
12.44 |
16.84 |
7.08 |
| Balance Sheet Total(BT) |
274.60 |
100.00 |
271.26 |
100.00 |
237.93 |
100.00 |
|
| As on |
31-Mar-06 |
31-Mar-05 |
31-Mar-04 |
| OPBIT/Prod.cap.empl.(%) |
28.93 |
20.80 |
20.65 |
| PBIT/Cap. Employed (%) |
27.64 |
21.25 |
19.88 |
| PAT/Networth (%) |
18.94 |
19.12 |
22.76 |
| Tax/PBT (%) |
28.80 |
31.32 |
21.30 |
| Total Debt/Networth (x) |
0.00 |
0.34 |
0.47 |
| Long Term Debt/Networth (x) |
0.00 |
0.00 |
0.00 |
| PBDIT/Finance Charges (x) |
164.74 |
99.90 |
148.31 |
| Current Ratio (x) |
2.02 |
2.90 |
3.07 |
| RM Inventory (days consumption) |
38.21 |
38.14 |
63.17 |
| FG inventory (days cost of sales) |
1.26 |
6.27 |
6.52 |
| Receivables (days gross sales) |
91.35 |
79.73 |
83.23 |
| Creditors (days cost of sales) |
62.99 |
39.45 |
69.24 |
| Op. curr. assets (days OI) |
153.00 |
231.00 |
259.00 |
|
|
Financials